212 related articles for article (PubMed ID: 9160518)
21. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
Wick MJ; Pfeifer JD
Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
[TBL] [Abstract][Full Text] [Related]
22. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
[TBL] [Abstract][Full Text] [Related]
23. Antigen expressed by Salmonella typhimurium is processed for class I major histocompatibility complex presentation by macrophages but not infected epithelial cells.
Harding CV; Pfeifer JD
Immunology; 1994 Dec; 83(4):670-4. PubMed ID: 7875747
[TBL] [Abstract][Full Text] [Related]
24. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
[TBL] [Abstract][Full Text] [Related]
25. The neonatal FcR-mediated presentation of immune-complexed antigen is associated with endosomal and phagosomal pH and antigen stability in macrophages and dendritic cells.
Liu X; Lu L; Yang Z; Palaniyandi S; Zeng R; Gao LY; Mosser DM; Roopenian DC; Zhu X
J Immunol; 2011 Apr; 186(8):4674-86. PubMed ID: 21402891
[TBL] [Abstract][Full Text] [Related]
26. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes.
Potter NS; Harding CV
J Immunol; 2001 Sep; 167(5):2538-46. PubMed ID: 11509593
[TBL] [Abstract][Full Text] [Related]
27. Cytosolic Delivery of Liposomal Vaccines by Means of the Concomitant Photosensitization of Phagosomes.
Hjálmsdóttir Á; Bühler C; Vonwil V; Roveri M; Håkerud M; Wäckerle-Men Y; Gander B; Johansen P
Mol Pharm; 2016 Feb; 13(2):320-9. PubMed ID: 26704885
[TBL] [Abstract][Full Text] [Related]
28. Dendritic cells process antigens encapsulated in a biodegradable polymer, poly(D,L-lactide-co-glycolide), via an alternate class I MHC processing pathway.
Gerelchuluun T; Lee YH; Lee YR; Im SA; Song S; Park JS; Han K; Kim K; Lee CK
Arch Pharm Res; 2007 Nov; 30(11):1440-6. PubMed ID: 18087813
[TBL] [Abstract][Full Text] [Related]
29. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.
Shen Z; Reznikoff G; Dranoff G; Rock KL
J Immunol; 1997 Mar; 158(6):2723-30. PubMed ID: 9058806
[TBL] [Abstract][Full Text] [Related]
30. Classical MHC class I peptide presentation of a bacterial fusion protein by bone marrow-derived dendritic cells.
Svensson M; Wick MJ
Eur J Immunol; 1999 Jan; 29(1):180-8. PubMed ID: 9933099
[TBL] [Abstract][Full Text] [Related]
31. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
[TBL] [Abstract][Full Text] [Related]
32. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
[TBL] [Abstract][Full Text] [Related]
33. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells.
Chen L; Jondal M
Eur J Immunol; 2004 Apr; 34(4):952-60. PubMed ID: 15048705
[TBL] [Abstract][Full Text] [Related]
34. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
Ramachandra L; Song R; Harding CV
J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
[TBL] [Abstract][Full Text] [Related]
35. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215
[TBL] [Abstract][Full Text] [Related]
36. Intracellular processing of hapten-modified protein for MHC class I presentation: cytoplasmic delivery by pH-sensitive liposomes.
Martin S; Niedermann G; Leipner C; Eichmann K; Weltzien HU
Immunol Lett; 1993 Aug; 37(2-3):97-102. PubMed ID: 8258464
[TBL] [Abstract][Full Text] [Related]
37. Investigation of endogenous antigen processing by delivery of an intact protein into cells.
Fu H; Ding J; Flutter B; Gao B
J Immunol Methods; 2008 Jun; 335(1-2):90-7. PubMed ID: 18406420
[TBL] [Abstract][Full Text] [Related]
38. The GTPase Rab39a promotes phagosome maturation into MHC-I antigen-presenting compartments.
Cruz FM; Colbert JD; Rock KL
EMBO J; 2020 Jan; 39(2):e102020. PubMed ID: 31821587
[TBL] [Abstract][Full Text] [Related]
39. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis.
Mukherjee P; Dani A; Bhatia S; Singh N; Rudensky AY; George A; Bal V; Mayor S; Rath S
J Immunol; 2001 Sep; 167(5):2632-41. PubMed ID: 11509605
[TBL] [Abstract][Full Text] [Related]
40. Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.
Dzierszinski F; Pepper M; Stumhofer JS; LaRosa DF; Wilson EH; Turka LA; Halonen SK; Hunter CA; Roos DS
Infect Immun; 2007 Nov; 75(11):5200-9. PubMed ID: 17846116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
